Elanco Animal Health Inc

ELAN

Company Profile

  • Business description

    Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

  • Contact

    2500 Innovation Way
    GreenfieldIN46140
    USA

    T: +1 877 352-6261

    E: greffet_james_f@elanco.com

    https://www.elanco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    9,800

Stocks News & Analysis

stocks

Microsoft earnings: Strength in cloud, guidance mixed

We think investors should be on board when Azure accelerates in the third quarter.
stocks

Chart of the week: Small caps lagging

This week's chart of the week comes from Morningstar's Market Strategist's take on small caps
stocks

An impending merger just raised our fair value for this ASX retail giant

The deal is set to deliver enhanced scale, cost savings and new synergies.  

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,422.1017.40-0.21%
CAC 407,350.3777.99-1.05%
DAX 4019,077.54179.80-0.93%
Dow JONES (US)41,763.46378.08-0.90%
FTSE 1008,110.1049.53-0.61%
HKSE20,317.3363.31-0.31%
NASDAQ18,095.15512.78-2.76%
Nikkei 22539,081.25196.14-0.50%
NZX 50 Index12,569.1969.71-0.55%
S&P 5005,705.45108.22-1.86%
S&P/ASX 2008,160.0020.40-0.25%
SSE Composite Index3,279.8213.590.42%

Market Movers